Lidocaine Versus Bupivacaine in Orthognathic Surgery

Launched by BOSTON CHILDREN'S HOSPITAL · Jun 7, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how two common local anesthetics, lidocaine and bupivacaine, affect patients' experiences after jaw surgery, known as orthognathic surgery. Both medications help numb the area to reduce pain, but they work in different ways and last for different amounts of time. By comparing these two, the researchers hope to learn which one provides a better recovery experience for patients.

To be eligible for this study, participants need to be between 15 and 35 years old and scheduled for an orthognathic procedure at Boston Children's Hospital. However, patients who have chronic pain, are pregnant, or are having other surgeries at the same time won’t be able to participate. Those who join the trial can expect to receive one of the anesthetics during their surgery and then share their experiences afterward, helping doctors improve pain management for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Undergoing an orthognathic procedure at Boston Children's Hospital
• • Between the ages of 15 and 35 years old
• Exclusion Criteria:
• • Any patient undergoing any other procedures in addition to their orthognathic procedure during the same sedation period (extraction, bone graft, etc.).
• • Any patient with a history of chronic pain.
• • Any patient with a history of an allergic reaction to bupivacaine or lidocaine.
• • Any patient with known neurologic changes to the lip or chin.
• • Any patient not enrolled in an Enhanced Recovery After Surgery (ERAS) Protocol.
• • Any patient known to be pregnant or with a positive pregnancy test prior to the procedure.